Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism

Clinical Trials
Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, evaluating the impact of early mechanical thrombectomy in patients with intermediate-risk pulmonary embolism (PE). The analysis compared patients treated with the Symphony...

Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism

Clinical Trials
Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, evaluating the impact of early mechanical thrombectomy in patients with intermediate-risk...

VahatiCor enrolls first U.S. patient in SERRA-I clinical study of A-FLUX Reducer System

Clinical Trials
VahatiCor has enrolled the first U.S. patient in its SERRA-I early feasibility study, evaluating the investigational A-FLUX Reducer System® for patients with coronary microvascular...

FiberSense to bring new CGM to European market with CE mark

Regulatory Approvals
FiberSense has received CE mark approval for its continuous glucose monitoring (CGM) system, allowing the company to move toward commercialization in selected European markets. The...

GS MedTech Funding Tracker – Nyxoah, Wise, and more

GS Funding Tracker
A strong signal of execution across the sector this week, with MedTech companies raising capital to accelerate commercialization, expand clinical adoption, and strengthen U.S....

Get Weekly Newsletter

[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism

Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, evaluating the impact of early mechanical thrombectomy in patients with intermediate-risk...

VahatiCor enrolls first U.S. patient in SERRA-I clinical study of A-FLUX Reducer System

VahatiCor has enrolled the first U.S. patient in its SERRA-I early feasibility study, evaluating the investigational A-FLUX Reducer System® for patients with coronary microvascular...

Raydiant Oximetry completes enrollment of First 15 Patients in IDE Pilot Study

Raydiant Oximetry has completed enrollment and data collection for the first 15 patients in its FDA-approved IDE pilot study at LSU Health Shreveport, advancing...

Airiver treats first patient in drug-coated balloon study for chronic rhinosinusitis

Airiver Medical has announced the first patient treatment in its RESTORE-2 pivotal clinical trial evaluating its ESSpand drug-coated balloon (DCB) for chronic rhinosinusitis (CRS). The...

Innovation

Regulatory Approvals

Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism

Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, evaluating the impact of early mechanical thrombectomy in patients with intermediate-risk...

VahatiCor enrolls first U.S. patient in SERRA-I clinical study of A-FLUX Reducer System

VahatiCor has enrolled the first U.S. patient in its SERRA-I early feasibility study, evaluating the investigational A-FLUX Reducer System® for patients with coronary microvascular...

FiberSense to bring new CGM to European market with CE mark

FiberSense has received CE mark approval for its continuous glucose monitoring (CGM) system, allowing the company to move toward commercialization in selected European markets. The...

GS MedTech Funding Tracker – Nyxoah, Wise, and more

A strong signal of execution across the sector this week, with MedTech companies raising capital to accelerate commercialization, expand clinical adoption, and strengthen U.S....

M&A

Archives

Latest articles

Load more

Popular categories

Funding1158Regulatory Approvals1028Innovation656Clinical Trials529Mergers & Acquisitions511GS Funding Tracker54